This study has provided theoretical reference for further study on the anti-tumor mechanism of VP-16.
从而为医学工作者进一步了解和探讨VP-16的抗肿瘤机理提供了直接的理论依据。
2
CONCLUSION: Intrapericardial infusion of VP-16 and DDP is an effective treatment for malignant pericardial effusion of NSCLC.
结论：心包穿刺抽液加心包腔内注入VP - 16联合DDP是恶性心包积液有效的治疗方法。
3
Methods 56 patients with SCLC were randomly divided into treatment group and control group receiving ce (Carboplatin, Etoposide VP-16) regimen plus Lifein or ce regimen alone respectively.